| Translational - CNIO

Home | News | Translational

Translational

Translational
10.04.2025
Nuclear Medicine and Biology. Compounds that visualise and treat cancer at the same time are proving to be effective in experimental models of triple-negative breast cancer The motto We see what we treat, we treat what we see sums them up well. They are theragnostic drugs,...
Unidad de Investigación Clínica en Inmunoterapia del Cáncer H12O-CNIO Translational
24.03.2025
Blood. A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of...
Novaseq X Plus sequencer Translational
04.03.2025
What is genomic information and why is it important for precision medicine? The European project Genome of Europe (GoE) will generate the most exhaustive genetic database of...
Unidad de Investigación Clínica de Oncohematología Pediátrica IdiPAZ-CNIO. / Laura M. Lombardía. CNIO Translational
14.02.2025
International Childhood Cancer Day. CNIO researchers seek more effective immunotherapies for children with cancer Pediatric cancer is relatively rare, yet it is the leading cause of death by disease in children and...
Eva González Suárez. / Laura M. Lombardía. CNIO Translational
23.01.2025
Eva González Suárez will advance towards the development of new inhibitors against breast cancer with a new grant from the European Research Council Breast cancer is the most common disease among women in the Western world. It causes half a million...
Gonçalo Bernardes. / Laura M. Lombardía. CNIO. Translational
15.01.2025
Gonçalo Bernardes’ new group at CNIO seeks to develop the next precision drugs against cancer Portuguese researcher Gonçalo Bernardes, a professor at the University of Cambridge (UK), is...
Leonardo Garma and Miguel Quintela, in the laboratory of the CNIO Breast Cancer Clinical Unit. Credit: Laura M. Lombardía / CNIO Translational
28.11.2024
Genome Medicine. Are ‘epigenetic clocks’ reliable? CNIO researchers refine the accuracy of these tests that measure ageing Among the most widely used tools today to measure the deterioration of the organism over time are...
Here comes the era of proteomics. Infographic by Cireniasketches. Translational
26.11.2024
Here comes the ‘era of proteomics’: a technology that analyses proteins in record time brings personalised medicine a step closer Medical treatments are increasingly adapted to the genetic traits of patients, because more and more...
From the left: María Casanova-Acebes, Sandra Demaria and Karin de Visser. Credit: Antonio Tabernero / CNIO. Translational
18.10.2024
Three experts explain how research is being done to make immunotherapy effective in an increasing number of breast cancers Immunotherapy has become the most promising strategy for treating cancer, but its effectiveness is...

Up

CNIO
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.